Lorazepam antibody
-
- Target
- Lorazepam
- Reactivity
- Chemical
- Host
-
Sheep
- Clonality
- Polyclonal
- Application
- ELISA, Dot Blot (DB), Immunoassay (IA), Immunohistochemistry (IHC), Western Blotting (WB)
- Specificity
- ELISA microtitre plate based and expressed as % crossreactivity*. The antibody exhibited crossreactivity for the following compounds: Oxazepam 6.8 % ,Nitrazepam < 6.8 %,Flunitrazepam < 6.8 %,7- Aminoflunitrazepam < 6.8 %,Clobazam< 6.8 %,Clonazepam 19.7 %,7-Aminoclonazepam < 6.8 %,Diazepam < 6.8 %,Nordiazepam 16.6 %,Temazepam <6.8 %,Alprazolam < 6.8 %,Triazolam < 7.9,Bromazepam < 7.9 %, Prazepam < 7.9 %, * crossreactivity profile may vary with tracer used.
- Purification
- Ig Fraction
- Immunogen
- Lorazepam-BSA/KLH
-
- Application Notes
- 1.25 µg/mL (EIA)
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 13.52 mg/mL (U.V. abs at 280 nm)
- Buffer
- 20 mM Phosphate, 150 mM NaCl
- Storage
- 4 °C
-
- Target
- Lorazepam
- Target Type
- Chemical
- Background
- The benzodiazepines are a group of over 20 structurally related central nervous system depressant drugs, each group varying considerably in their potency and clinical effects.
-